Large-Vessel Vasculitis

New Treatment Strategies in Large-vessel Vasculitis

Image result for large vessel vasculitisImage result for large vessel vasculitis

Will biologics have a place in the treatment of large-vessel vasculitis?

Abatacept efficacy differs in trials of Giant Cell and Takayasu’s arteritis

A pair of new studies offer mixed results regarding the use of the rheumatoid arthritis drug abatacept to treat two forms of large-vessel vasculitis: It appears to…

Abatacept Efficacy Giant Cell Arteritis

A novel trial from Dr. Carol Langford and colleagues has reported the results of a 49 patient trial of newly-diagnosed or relapsing GCA where all patients were treated…

Multiple Comorbidity Risks with Giant Cell Arteritis

Elderly patients treated with high doses of corticosteroids are bound to have multiple medical…

Causes of Cardiovascular Ischemic Events in Giant Cell Arteritis

Giant cell arteritis (GCA) is a granulomatous vasculitis with rising incidence in the sixth to eighth decade of age, when cardiovascular (CV) events put survival,…

Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis

Giant cell arteritis (GCA) and the use of glucocorticoids have both been associated with increased risk of venous thromboembolism (VTE). However,…

Prior Infections Likely a 'Minor Determinant' of Overall GCA Risk

Herpes zoster in particular doesn't seem to play causal role

Comments are closed.